Estharla Madhu Rekha

Author

Birla Institute of Technology and Science, Pilani ORCID

Also Known As

E M Rekha, Estharla M. Rekha, Estharla Madhu Rekha, Madhu Rekha Estharla, Madhurekha Estharala, Rekha, Estharla Madhu

Publications

318

Citations

H-Index

Concepts

All Affiliations

Birla Institute of Technology and Science, Pilani Birla Institute of Technology and Science - Hyderabad Campus Dr. Babasaheb Ambedkar Marathwada University Bharati Vidyapeeth Deemed University The University of Queensland

About

Estharla Madhu Rekha is an author at Birla Institute of Technology and Science, Pilani specializing in drug discovery, medicine, and pharmacology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	6	6	224
2	Biochemistry	3	3	109
3	Natural Sciences	2	2	54
4	Biomedical Engineering	1	1	15
5	Chemical Biology	1	1	23

Estharla Madhu Rekha

Publications

278

Citations

H-Index

Page 1

	Year	Citations
Novel isoniazid embedded triazole derivatives: Synthesis, antitubercular and antimicrobial activity evaluation Pravin Patil, Sanghratna L. Kasare, Nitin B. Haval, Bioorganic & Medicinal Chemistry Letters Derivative (Chemistry)Antimicrobial Activity EvaluationMedicineTriazole DerivativesOrganic Chemistry	2020	66
Discovery and evaluation of novel Mycobacterium tuberculosis ketol-acid reductoisomerase inhibitors as therapeutic drug leads Vagolu Siva Krishna, Shan Zheng, Estharla Madhu Rekha, Journal of Computer-Aided Molecular Design Pulmonary TuberculosisBiochemistryMedicineTuberculosisPharmacotherapy	2019	55
Design, synthesis and antitubercular assessment of 1, 2, 3-triazole incorporated thiazolylcarboxylate derivatives Rajubai D. Bakale, Shubham M. Sulakhe, Sanghratna L. Kasare, Bioorganic & Medicinal Chemistry Letters Medicinal ChemistryAntitubercular AssessmentDerivativesDerivative (Chemistry)Medicine	2023	34
Synthesis of isoniazid‐1,2,3‐triazole conjugates: Antitubercular, antimicrobial evaluation and molecular docking study Adinath D. Badar, Shubham M. Sulakhe, Mahesh B. Muluk, Journal of Heterocyclic Chemistry Antimicrobial EvaluationOrganic ChemistryAntimicrobial ChemotherapyChemistryPharmaceutical Chemistry	2020	31
Design and development of ((4-methoxyphenyl)carbamoyl) (5-(5-nitrothiophen-2-yl)-1,3,4-thiadiazol-2-yl)amide analogues as Mycobacterium tuberculosis ketol-acid reductoisomerase inhibitors Vagolu Siva Krishna, Shan Zheng, Estharla Madhu Rekha, European Journal of Medicinal Chemistry Medicinal ChemistryBioorganic ChemistryBiochemistryNatural SciencesMedicine	2020	23
<i>In vitro</i> and <i>in silico</i> exploration of newly synthesized triazolyl- isonicotinohydrazides as potent antitubercular agents Rajubai D. Bakale, Pramod S. Phatak, Sanket Rathod, Journal of Biomolecular Structure and Dynamics	2023	23
S-alkylated thiosemicarbazone derivatives: Synthesis, crystal structure determination, antimicrobial activity evaluation and molecular docking studies Miyase Gözde Gündüz, Büşra Kaya, Ceren Özkul, Journal of Molecular Structure	2021	16
Synthesis of novel 4,5‐dihydropyrrolo[1,2‐<i>a</i>]quinoxalines, pyrrolo[1,2‐<i>a</i>]quinoxalin]‐2‐ones and their antituberculosis and anticancer activity Vitthal B. Makane, Eruva Vamshi Krishna, Uattam B. Karale, Archiv der Pharmazie	2020	15
Design and synthesis of novel quinazolinyl-bisspirooxindoles as potent anti-tubercular agents: an ultrasound-promoted methodology Bhargava Sai Allaka, Srinivas Basavoju, Estharla Madhu Rekha, Molecular Diversity Medicinal ChemistryNovel Quinazolinyl-bisspirooxindolesMedicineBiomedical EngineeringPotent Anti-tubercular Agents	2022	15

Page 1